June 13, 2018
Rose
Switzerland-based MindMaze announced today that it has received FDA clearance for the MindMotion Go, a gamified neurorehabilitation therapy platform for medium and light severity impairments able to be deployed in the patient’s home. Using motion capture technology based on the Microsoft Kinect, the Go engages patients with a range of activities set in displayed 3D environments that promote motor and task functions.
from MobiHealthNews https://ift.tt/2sT552j
June 13, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Innovation moving faster than precision medicine policy- Digital network for behavioral health SonderMind raises $2.5M
- Castlight looks ahead to new platform launches during Q1 earnings call
- Greenstein departs HHS and more digital health hires and departures
- Dexcom outperforms growth expectations but proceeds with caution
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment